CLASS II Device recall · Reported 29 Aug 2018 · FDA Enforcement Report

BD BBL GC-Lect Agar recalled by Becton Dickinson &

Becton Dickinson is recalling BD BBL GC-Lect Agar, distributed in 29 states. The recall was initiated on 21 Jun 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codes8110781
Quantity recalled10,360 plates

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2869-2018
FDA event ID
80573
Recalling firm
Becton Dickinson, Sparks, MD
Classification
Class II
Status
Terminated
Recall initiated
21 Jun 2018
FDA classified
17 Aug 2018
Reported
29 Aug 2018
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Other Reasons

Timeline

21 Jun 2018Recall initiated by company
17 Aug 2018Classified by FDA+57 days
29 Aug 2018Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

A portion of this lot was manufactured using Gentamicin instead of Vancomycin. Gentamicin is an inhibitory agent of Neisseria organisms. This product is a selective plated medium to provide enhanced growth and recovery of N gonorrhoeae. Inhibited growth may cause a false negative result or a delayed result leading to incorrect or delayed treatment.

Product as listed by the FDA

BD BBL GC-Lect Agar; Cat. No. 297715 The device is a selective medium providing enhanced growth and recovery of Neisseria gonorrhoeae and better inhibition of contamination bacteria and fungi.

Where it was distributed

US Distribution in states of: AK, AL, AR, AZ, CA, CO, DC, DE, FL, GA, HI, ID, IN, KS, KY, MA, MI, MS, MT, NC, JH, NY, OK, OR, PA, SC, TN, TX, WA, and WI.

AlaskaAlabamaArkansasArizonaCaliforniaColoradoDistrict of ColumbiaDelawareFloridaGeorgiaHawaiiIdahoIndianaKansasKentuckyMassachusettsMichiganMississippiMontanaNorth Carolina

Questions about this recall

Why was it recalled?

A portion of this lot was manufactured using Gentamicin instead of Vancomycin. Gentamicin is an inhibitory agent of Neisseria organisms. This product is a selective plated medium to provide enhanced growth and recovery of N gonorrhoeae. Inhibited growth may cause a false negative result or a delayed result leading to incorrect or delayed treatment.

Which lots are affected?

8110781

Where was it sold?

US Distribution in states of: AK, AL, AR, AZ, CA, CO, DC, DE, FL, GA, HI, ID, IN, KS, KY, MA, MI, MS, MT, NC, JH, NY, OK, OR, PA, SC, TN, TX, WA, and WI.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Becton Dickinson

All 364

Other Other Medical Devices recalls

All 13,778